(Last updated : 2026-05-26 19:41:26)
  Hideaki Kaneto
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of Diabetes, Endocrinology and Metabolism,
   Position   Professor
■ Journal Articles
1. 4043/12/25 Severe hypercholesterolemia caused by mesalazine which is the key drug of ulcerative colitis: A case report 
2. 2026/05/16 Postprandial reactive hypoglycemia due to disproportionate insulin secretion in young adult Japanese females with normal weight and childhood obesity: A three-case series with a review of literature 
3. 2026/04 Effect of metformin dose reduction versus continuation at imeglimin initiation on glycemic control in type 2 diabetes: a retrospective real-world analysis 
4. 2026/03/01 Diabetic Ketoacidosis Associated with Non-occlusive Mesenteric Ischemia in a Subject with Type 2 Diabetes Mellitus: A Case Report 
5. 2026/02 Correlation between diabetes complications severity index and actual complication severity and diabetic medication in Japanese patients with type 2 diabetes mellitus 
Display all(267)
■ Presentations
1. 2024/09/11 Elucidation of a new mechanism of action of GLP-1 focusing on pancreatic islet blood flow - Investigation by in vivo imaging - (Speech,General) 
2. 2023/06/24 DPP-4 inhibitor and SGLT2 inhibitor additively ameliorate hepatic steatosis in NAFLD model mice through different action mechanisms (Poster notice,General) 
3. 2023/06/24 GLP-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes ~Randomized, parallel-group, multicenter, open-label trial~ (Poster notice,General) 
4. 2023/06/24 Protective effects of DPP-4 inhibitor and SGLT2 inhibitor on pancreatic β-cell function: Randomized, parallel-group, multicenter, open-label study (SECRETE-I) (Poster notice,General) 
5. 2018/06/25 Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic beta cells in obese diabetic db/db mice - ‘‘The earlier and longer, the better’’ (Poster notice,General) 
Display all(16)